ZURICH/MILAN (Reuters) - Italy's antitrust authorities said Swiss drugmakers Novartis and Roche colluded to try to stop cancer drug Avastin being used to treat a serious eye disease, and fined the companies 182.5 million euros ($251 million). In a statement on Wednesday, Italy's regulator accused the two Basel-based firms of striking an alliance to prevent distribution of Roche's Avastin as a treatment for wet age-related macular degeneration (AMD) in favor of the more expensive drug Lucentis made by Novartis. It fined Novartis 92 million euros ($126.4 million) and Roche 90.5 million euros. Novartis and Roche strongly denied the regulator's assertions and said they would appeal.
via Health News Headlines - Yahoo News http://ift.tt/1cCDeT1
No comments:
Post a Comment